CMV IgG Positive and Kidney Donation: Risk Assessment and Management
CMV IgG+ = past CMV infection (latent virus). Common: 50–80% adults seropositive. In kidney transplantation, serostatus matching affects post-transplant CMV disease risk.
Donor/Recipient Risk Matrix
| Donor | Recipient | Risk Level | Key Concern |
|---|---|---|---|
| IgG+ | IgG– | Highest (D+/R–) | Primary CMV infection in immunocompromised host → tissue-invasive disease, rejection risk, mortality |
| IgG+ | IgG+ | Moderate (D+/R+) | Reactivation or reinfection; usually milder |
| IgG– | IgG+ | Low (D–/R+) | Recipient reactivation only |
| IgG– | IgG– | Lowest (D–/R–) | No CMV exposure source |
Does IgG+ Disqualify Donation?
No. CMV IgG+ donors are routinely accepted. Risk is managed, not avoided.
Mitigation Strategies
- Prophylaxis: Valganciclovir 900mg daily × 3–6 months (D+/R– standard).
- Preemptive therapy: Weekly CMV PCR monitoring; treat at threshold (e.g., >1000 IU/mL).
- Antiviral prophylaxis also reduces other herpesviruses (HSV, VZV, EBV).
- Enhanced monitoring for D+/R–: viral load, renal function, drug levels (valganciclovir myelosuppression).
Outcomes
- Modern prophylaxis → CMV disease <10% in D+/R–.
- Graft survival equivalent to matched pairs at 5 years.
- Donor IgG+ status alone does not reduce graft/patient survival.
Discuss your specific serostatus pairing with transplant team. Protocols vary by center.
Kidney Disease - Related Articles
- Hyperkalemia: Causes, Symptoms & Treatment - A Comprehensive Guide
- Glomerulonephritis: Types, Causes, Diagnosis & Treatment of Kidney Filter Inflammation
- Acute Renal Failure (ARF): Understanding Prognosis & Treatment
- End-Stage Renal Disease (ESRD): Causes, Symptoms & Treatment
- Kidney Failure: Can the Remaining Kidney Compensate?
- Kidney Ulcers: Symptoms, Causes & Pain Relief
- Understanding Flank Pain: Causes & When to See a Doctor
